Outcomes of Patients with Splenic Marginal Zone Lymphoma Treated with Rituximab or Splenectomy: Report from Tertiary Cancer Center in India

被引：0
|
作者：
Bagal, Bhausaheb [1 ]
Mandal, Tanmoy [1 ]
Bonda, Avinash [1 ]
Punatar, Sachin [1 ]
Gokarn, Anant [1 ]
Tembhare, Prashant [1 ]
Jain, Hasmukh [1 ]
Patkar, Nikhil [1 ]
Epari, Sridhar [1 ]
Sengar, Manju [1 ]
Khattry, Navin [1 ]
Shet, Tanuja [1 ]
Gujral, Sumit [1 ]
Banavali, Shripad [1 ]
机构：
[1] Tata Mem Hosp, Bombay, Maharashtra, India
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷
关键词：
Splenic marginal zone lymphoma; Splenectomy; Rituximab;
D O I：
10.1016/j.clml.2018.07.216
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NHL-185
引用
收藏
页码：S282 / S283
页数：2
相关论文
共 50 条
  • [1] Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone
    Tsimberidou, Apostolia M.
    Catovsky, Daniel
    Schlette, Ellen
    O'Brien, Susan
    Wierda, William G.
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Wen, Sijin
    Do, Kim-Anh
    Lerner, Susan
    Keating, Michael J.
    CANCER, 2006, 107 (01) : 125 - 135
  • [2] Splenic marginal zone lymphoma treated with laparoscopic splenectomy: A case report
    Koyama, Ryota
    Minagawa, Nozomi
    Maeda, Yoshiaki
    Shinohara, Toshiki
    Hamada, Tomonori
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2019, 65 : 288 - 291
  • [3] Rituximab monotherapy in splenic marginal zone lymphoma instead of splenectomy
    Bennett, M.
    Yegena, S.
    Chubar, E.
    Schechter, G. P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 45 - 45
  • [4] SPLENECTOMY VERSUS RITUXIMAB IN THE TREATMENT OF SPLENIC MARGINAL ZONE LYMPHOMA
    Kalpadakis, C.
    Pangalis, G. A.
    Vassilakopoulos, T. P.
    Sachanas, S.
    Kyrtsonis, M. C.
    Dimopoulou, M.
    Korkolopoulou, P.
    Kontopidou, F. N.
    Yiakoumis, X.
    Siakantaris, M. P.
    Dimitriadou, E. M.
    Panayiotidis, P.
    Papadaki, H.
    Angelopoulou, M. K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 168 - 169
  • [5] Treatment of Splenic Marginal Zone Lymphoma: Splenectomy Versus Rituximab
    Bennett, Michael
    Schechter, Geraldine P.
    SEMINARS IN HEMATOLOGY, 2010, 47 (02) : 143 - 147
  • [6] Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era
    Starr, Adam G.
    Caimi, Paolo F.
    Fu, PingFu
    Massoud, Mira R.
    Meyerson, Howard
    Hsi, Eric D.
    Mansur, David B.
    Cherian, Sheen
    Cooper, Brenda W.
    De Lima, Marcos J. G.
    Lazarus, Hillard M.
    Gerson, Stanton L.
    Jagadeesh, Deepa
    Smith, Mitchell R.
    Dean, Robert M.
    Pohlman, Brad L.
    Hill, Brian T.
    William, Basem M.
    HEMATOLOGY, 2017, 22 (07) : 405 - 411
  • [7] Comparative outcomes of splenectomy and rituximab-based chemotherapy in elderly patients with splenic marginal zone lymphoma
    Olszewski, Adam J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Treatment of Splenic Marginal Zone Lymphoma With Rituximab Monotherapy: Progress Report and Comparison With Splenectomy
    Kalpadakis, Christina
    Pangalis, Gerassimos A.
    Angelopoulou, Maria K.
    Sachanas, Sotirios
    Kontopidou, Flora N.
    Yiakoumis, Xanthi
    Kokoris, Stella I.
    Dimitriadou, Evagelia M.
    Dimopoulou, Maria N.
    Moschogiannis, Maria
    Korkolopoulou, Penelope
    Kyrtsonis, Marie-Christine
    Siakantaris, Marina P.
    Papadaki, Theodora
    Tsaftaridis, Panayiotis
    Plata, Eleni
    Papadaki, Helen E.
    Vassilakopoulos, Theodoros P.
    ONCOLOGIST, 2013, 18 (02): : 190 - 197
  • [9] Should rituximab replace splenectomy in the management of splenic marginal zone lymphoma?
    Kalpadakis, Christina
    Pangalis, Gerassimos A.
    Angelopoulou, Maria K.
    Sachanas, Sotirios
    Vassilakopoulos, Theodoros P.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2018, 31 (01) : 65 - 72
  • [10] Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma
    Olszewski, Adam J.
    Ali, Shihab
    ANNALS OF HEMATOLOGY, 2014, 93 (03) : 449 - 458
12345